B3GAT1 and hepatocellular carcinoma: While there was not any notable difference in CD57+ CD4+ T cells among those groups (Supplementary Figure S1D), the percentage of CD3+CD8+ T cells was lower in ARLD patients compared to viral hepatitis with HCC (Supplementary Figure S1E).